The global tuberculous meningitis treatment market is poised for steady growth over the next decade, with its valuation expected to rise from USD 172,377.6 million in 2025 to USD 339,092.8 million by 2035, according to market projections. This growth, driven by a compound annual growth rate (CAGR) of 7%, is attributed to increasing global TB …
Author Archives: Pranali Shahapurkar
Global Large Granular Lymphocytic Leukemia (LGLL) Therapeutics Market to Reach USD 17,051.4 Million by 2035, Driven by Targeted Therapy Innovation and Enhanced Diagnostics | FMI
The global large granular lymphocytic leukemia therapeutics market is poised for significant expansion over the next decade, underpinned by improvements in diagnostic capabilities, the development of novel targeted therapies, and increased awareness and recognition of rare blood cell malignancies. According to market forecasts, the market is anticipated to surge from USD 3,865.2 million in 2025 …
Vaginal and Vulval Inflammatory Diseases Treatment Market to Surpass USD 5,500.7 Million by 2035 Amid Rising Awareness and Technological Innovation | FMI
The global vaginal and vulval inflammatory diseases treatment market is poised for significant growth over the next decade, driven by a rising prevalence of gynecological conditions, expanding healthcare access, and innovation in treatment modalities. According to recent market projections, the sector is expected to grow from USD 3,313.3 million in 2025 to USD 5,500.7 million …
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Treatment Market to Surpass USD 9,578.28 Million by 2035: Driven by Targeted Therapies, Clinical Trials, and Technological Innovation | FMI
The global progressive fibrosing interstitial lung disease (PF-ILD) treatment market is witnessing robust growth, fueled by an alarming increase in interstitial lung diseases (ILDs), greater clinical awareness, and continuous innovation in diagnostics and therapies. In 2025, the PF-ILD treatment market is projected to be valued at USD 5,348.46 million and is anticipated to reach USD …
Global Idiopathic Pulmonary Fibrosis Management Market to Reach USD 3,850.1 Million by 2035 Amidst Steady Advances in Therapy and Diagnosis | FMI
The global idiopathic pulmonary fibrosis management market is poised for moderate yet consistent growth, with its valuation projected to rise from USD 3,252.8 million in 2025 to USD 3,850.1 million by 2035, reflecting a CAGR of 1.7% during the forecast period. The market’s expansion is underpinned by an increasing global burden of IPF, accelerated innovation …
Global Transfusion Dependent Thalassaemia Management Market to Reach USD 21.5 Million by 2035, Driven by Breakthroughs in Gene Therapy and Iron Chelation Treatments | FMI
The global transfusion dependent thalassaemia management market is on a steady growth trajectory, projected to rise from USD 11.2 million in 2025 to USD 21.5 million by 2035, at a robust compound annual growth rate (CAGR) of 6.5%. This expansion is largely driven by advancements in gene therapies, blood transfusion technologies, and iron chelation treatments, …
Global Ringworm Treatment Market Set to Surpass USD 15,106.66 Million by 2035 Amid Rising Fungal Infections and OTC Drug Accessibility | FMI
The global ringworm treatment market is poised for robust expansion, projected to grow from USD 9,274.18 million in 2025 to USD 15,106.66 million by 2035, reflecting a compound annual growth rate (CAGR) of 5% over the forecast period. This growth is largely fueled by a surge in fungal skin infections, rising consumer awareness around personal …
Global Aarskog-Scott Syndrome Treatment Market Set to Surge to USD 6.4 Billion by 2035, Driven by Genetic Innovations and Personalized Care | FMI
The global aarskog-scott syndrome treatment market is witnessing a transformative phase, with technological breakthroughs, personalized therapeutic strategies, and government-backed research initiatives reshaping patient care. As the healthcare industry turns its attention to rare genetic disorders, the Aarskog-Scott Syndrome (AAS) treatment market is projected to grow from USD 3.6 billion in 2025 to USD 6.4 billion …
Global Acrocallosal Syndrome Therapeutics Market Poised for Significant Growth, Projected to Reach USD 488.3 Million by 2035
The global acrocallosal syndrome therapeutics market a rare and complex genetic disorder characterized by agenesis of the corpus callosum, polydactyly, and distinct craniofacial anomalies—is set to experience transformative growth over the next decade. According to recent market analysis, the ACS therapeutics market is projected to rise from USD 181.5 million in 2025 to approximately USD …
Global Adrenogenital Syndrome Treatment Market to Reach USD 24.5 Billion by 2035, Driven by Technological Advancements and Rising Awareness | FMI
The global adrenogenital syndrome treatment market is poised for sustained growth, expected to expand from USD 14.2 billion in 2025 to USD 24.5 billion by 2035, registering a compound annual growth rate (CAGR) of 5.6% over the forecast period. The robust growth trajectory is attributed to technological innovations, rising disease awareness, improved diagnostics, and significant …